SECURITY AGREEMENT


    THIS SECURITY AGREEMENT (the "Agreement") is made as of the 26th day of 
June, 1996, between Bioject Inc. an Oregon corporation (the "Company"), and 
Schering Aktiengesellschaft, a corporation organized under the laws of Germany 
(the "Secured Party").

                                 RECITALS

    A.   Prior to the date of this Agreement, Secured Party's affiliate Berlex 
Laboratories, Inc. made a loan to the Company in the amount of $450,000.  That 
loan was evidenced by a Secured Promissory Note dated April 22, 1996 (the 
"Berlex Note") and was secured in accordance with a Security Agreement dated 
April 22, 1996 (the "Berlex Security Agreement").

    B.   Secured Party has purchased the Berlex Note and has agreed to make 
additional advances to the Company as provided in Section 3.13 of a Supply 
Agreement between the Company and the Secured Party dated the same date as 
this Agreement (the "Supply Agreement").  All sums due under the Berlex Note 
are now reflected in the Supply Agreement, and the Berlex Note is cancelled 
and the Berlex Security Agreement is terminated upon the execution of this 
Agreement; and

    C.   The Company has agreed to grant to Secured Party a security interest 
in certain assets of the Company as security for the prompt payment by the 
Company of its obligations to repay sums borrowed under Section 3.13 of the 
Supply Agreement as it may be modified or amended from time to time (the 
"Obligations").

    NOW, THEREFORE, in consideration of the mutual covenants and agreements 
set forth herein and for other good and valuable consideration, the receipt 
and adequacy of which are hereby acknowledged, the parties hereby agree as 
follows:

    1.   Security Interest.  Pursuant to the provisions of the Oregon Uniform 
Commerce Code (the "Code"), the Company hereby grants to Secured Party a 
security interest in the following (the "Collateral"):

         1.1  The deposit account, which will contain only the proceeds of the 
Berlex Note and the additional amounts loaned to the Company pursuant to 
Section 3.13 of the Supply Agreement until such time as the Equipment (as 
defined in Section 1.2) is purchased, plus interest earned on that deposit 
account (the "Deposit Account").

         1.2  All of the Company's right, title and interest in and to any and 
all tooling and equipment purchased by the Company in connection with the 
Supply Agreement with sums from the Deposit Account, including but not limited 
to, syringe molds, tooling and molds for autoinjectors, and equipment to 
automate the manufacture of syringes.

         1.3  Any and all proceeds whether receivable or received from or upon 
the sale, lease, license, use, exchange or other disposition, whether 
voluntary or involuntary, of any Equipment, including "proceeds" as defined in 
Section 9-306 of the Code, any and all proceeds of any insurance, indemnity, 
warranty or guaranty payable to or for the account of the Company from time to 
time with respect to any of the Equipment, and any and all other amounts from 
time to time paid or payable under or in connection with any of the Equipment.  
Proceeds pursuant to this Agreement include (i) whatever is now or 
subsequently received by the Company upon the sale, exchange, collection or
other disposition at anytime of Equipment, whether such proceeds constitute 
inventory, accounts, accounts receivable, general intangibles, instruments, 
securities, credits, documents, letters of credit, chattel paper, documents of 
title, warehouse receipts, leases, deposit accounts, money, contract rights, 
goods or equipment, and (ii) any such items which are now or subsequently
acquired by the Company with any proceeds of Collateral.

    2.   Performance Secured.  The security interest granted hereby secures 
the prompt payment of the Obligations. 

    3.   Covenants of the Company.  The Company covenants and agrees, unless 
compliance is waived in writing by Secured Party, that:

         3.1  Maintenance of Collateral.  The Company will properly maintain 
and care for the Collateral.

         3.2  Sale of Collateral.  The Company will not sell, transfer, trade 
or otherwise dispose of all or substantially all of the Collateral, except 
with the consent of Secured Party or as expressly contemplated in Section 1.2.

         3.3  Change in Company.  The Company will notify Secured Party in 
writing of any proposed or actual change of the Company's name, identity or 
corporate structure.

         3.4  Payment of Taxes.  The Company will pay prior to delinquency all 
taxes, liens and assessments which are levied or assessed against the 
Collateral.

         3.5  Perfection Filing.  The Company will file the Form UCC-1 
Financing Statement (the "UCC-1") in the form mutually agreed upon with the 
Office of the Oregon Secretary of State within five (5) business days after 
the date of this Agreement.

    4.   Events of Default.  The occurrence of any of the following shall 
constitute an Event of Default under this Agreement:

         4.1  Payment of Notes.  The Company fails to make any payment of 
principal or interest when required with respect to the Obligations.

         4.2  Bankruptcy, Insolvency, etc. Commenced by the Company.  If the 
Company:

         (a)  shall commence any proceeding or any other action relating to it 
in bankruptcy or seek reorganization, arrangement, readjustment of its debts, 
dissolution, liquidation, winding-up, composition or any other relief under 
the United States Bankruptcy Act, as amended, or under any other insolvency,
reorganization, liquidation, dissolution, arrangement, composition, 
readjustment of debt or any other similar act or law, of any jurisdiction, 
domestic or foreign, now or hereafter existing;

         (b)  shall admit its inability to pay its debts as they mature in any 
petition or pleading in connection with any such proceeding;

         (c)  shall apply for, or consent to or acquiesce in, an appointment 
of a receiver, conservator, trustee or similar officer of it or for all or 
substantially all of its assets and properties; or

         (d)  shall make a general assignment for the benefit of creditors.

         4.3  Bankruptcy, Insolvency, etc. Commenced Against the Company. If 
any proceedings are commenced or any other action is taken against the Company 
in bankruptcy or seeking reorganization, arrangement, readjustment of its 
debts, dissolution, liquidation, winding-up, composition or any other relief 
under the United States Bankruptcy Act, as amended, or under any other 
insolvency, reorganization, liquidation, dissolution, arrangement, 
composition, readjustment of debt or any other similar act or law, of any 
jurisdiction, domestic or foreign, now or hereafter existing; or a receiver, 
conservator, trustee or similar person for the Company or for all or 
substantially all of its assets and properties is appointed; and in each such 
case, such event continues for ninety (90) days undismissed, unbonded and 
undischarged.

    5.   Secured Party's Remedies after Default.  Upon the occurrence of an 
Event of Default, Secured Party may, after delivering written notice of such 
Event of Default to the Company, do any one or more of the following:

         5.1  Accelerate Obligations.  Declare the outstanding principal 
balance of the Obligations, together with the accrued but unpaid interest 
thereon, immediately due and payable.

         5.2  Actions Against the Company.  Proceed against the Company with 
or without proceeding against the Collateral secured hereby.

         5.3  Actions Against the Collateral.  Exercise all of the rights and 
remedies provided to Secured Party by this Agreement, by the Code as then in 
effect, or any other applicable law.

    6.   General Provisions.

         6.1  Construction.  This Agreement shall be governed, construed and 
enforced in accordance with the internal laws of the State of Oregon.  All 
terms not defined herein are used as set forth in the Code.

         6.2  Entire Agreement.  This Agreement, together with the agreements 
and documents referred to herein, constitute the entire agreement among the 
parties hereto with respect to the subject matter hereof and supersede all 
prior and contemporaneous negotiations, agreements and understandings.

         6.3  Notices.  All payments, notices, requests, demands and other 
communications hereunder shall be in writing and shall be deemed to have been 
duly given (i) upon delivery if personally delivered or delivered by facsimile 
or (ii) on the third business day following the date deposited with a 
reputable overnight courier, to the party at the following address or at such 
other address as shall be given in writing by either party to the other
party:

    Secured Party:      Schering Aktiengesellschaft
                        Mullerstrasse 170-178
                        13353 Berlin, Germany

    The Company:        Bioject Inc.
                        7620 S.W. Bridgeport Road
                        Portland, Oregon 97224
                        Attention:  Chairman

         6.4  Successors and Assigns.  This Agreement shall inure to the 
benefit of, and shall be binding upon, the parties and their respective 
successors and assigns.

         6.5  Severability.  If one or more provisions of this Agreement are 
held to be unenforceable under applicable law, such provision shall be 
excluded from this Agreement and the balance of the Agreement shall be 
interpreted as if such provision were so excluded and shall be enforceable in 
accordance with its terms.

         6.6  Further Assurances.  Each party hereto will execute, 
acknowledge, and deliver any further assurances, documents and instruments 
reasonably requested by the other party hereto for the purpose of creating and 
perfecting Secured Party's security interest in the Collateral hereunder, 
including (without limitation) any financing statement, amended financing 
statement, continuation statement, or other instrument permitted or required
by the Code or other applicable law.

         6.7  Cooperation.  The Company and Secured Party each agrees from 
time to time to execute and deliver, or cause to be executed and delivered, 
such further instruments and do and cause to be done such further acts as may 
be necessary or appropriate to carry out more effectively the provisions of 
this Agreement.

         6.8  Amendments and Waiver.  The rights of Secured Party hereunder 
and under any financing statement, amended financing statement, continuation 
statement, or other document or instrument creating or perfecting the Secured 
Party's security interest in the Collateral may be amended or waived at any 
time by the written consent of the Secured Party and the Company.

         6.9  Termination.  Upon payment in full of the Obligations, the 
security interest provided under this Agreement shall automatically terminate 
and shall be deemed null and void.  Secured Party agrees to execute all 
appropriate instruments or other documentation (including one or more UCC-3 
Termination Statements) to evidence the termination of such security
interest.

         6.10 Counterparts.  This Agreement may be executed in one or more 
counterparts, each of which shall be deemed an original but all of which 
together shall constitute one and the same instrument.

    IN WITNESS WHEREOF, the undersigned have executed this Agreement, 
effective as of the date first written above.

THE COMPANY:                 BIOJECT INC.


                             By:  /S/ James C. O'Shea

                             Its:  Chairman                    


SECURED PARTY:                    SCHERING AKTIENGESELLSCHAFT


                             By:  [Confidential Portion Omitted]

                             Its: [Confidential Portion Omitted]